Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MEDRELEAF CORP T.LEAF

"MedReleaf Corp is engaged in the production and sale of cannabis for medical purposes as regulated by the ACMPR, pursuant to its Licences and, in particular, its Markham Commercial Licence."


TSX:LEAF - Post by User

Comment by longonMJon May 24, 2018 2:15am
198 Views
Post# 28073505

RE:ACB $8.47*3.575 = $30.28 LEAF

RE:ACB $8.47*3.575 = $30.28 LEAFIf I remember correctly, I believe the arbitrage discount on CMED lasted right through until just the week before the actual takeover.  So, we probably still have a long ways to go before this discount starts to dwindle back down.

I don't believe we even have a tentative date for this proposed takeover yet, as they still have to go through the shareholder voting first.

Not sure about the Canopy NYSE listing impact for some of these other big weed stocks.  Normally, I would expect them to follow Canopy's lead, but I m also starting to think that some of them might decide to jump off and take their profits now before boarding the Canopy bus for some faster and bigger gains short term.  Hmmm.....

MartialArts wrote:
Enjoy the $5 discount on LEAF while it lasts. The same thing happened with CMED until CMED caught up to the linked prices via the ratio.


With Canopy listing on the NYSE tomorrow, the sector will get a lot of new investors.

ACB will follow suit shortly.



<< Previous
Bullboard Posts
Next >>